The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. JAMA published three perspectives -- two welcoming ...
A Bayesian re-analysis of hundreds of published clinical trials shows that statistically negative studies can hide strong ...
Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
Three crew members of the Bayesian superyacht are officially under investigation for crimes including negligence, recklessness and failing to save the ship from an oncoming storm, according to Italian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results